The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase (Ph) 2 stage 1 clinical activity of seviteronel, a selective CYP17-lyase and androgen receptor (AR) inhibitor, in women with advanced AR+ triple-negative breast cancer (TNBC) or estrogen receptor (ER)+ BC: CLARITY-01.
 
Ayca Gucalp
Research Funding - Innocrin Pharma; Pfizer
 
Michael A. Danso
Honoraria - Amgen
Consulting or Advisory Role - Novartis
 
Anthony D. Elias
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Agilent; Allergan; Amgen; Biogen; Biomarin; Bristol-Myers Squibb; Cardinal Health; Celgene; Express Scripts; Gilead Sciences; Johnson & Johnson; Lilly; Merck; Pfizer; Teva
Consulting or Advisory Role - Genentech
Research Funding - Astellas Pharma (Inst); CytRx Corporation (Inst); Eisai (Inst); Eisai (Inst); Genentech (Inst); ImClone Systems (Inst); Incyte (Inst); Johnson & Johnson (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Genentech
 
Aditya Bardia
Consulting or Advisory Role - Genentech; Novartis
 
Haythem Y. Ali
No Relationships to Disclose
 
David Potter
No Relationships to Disclose
 
Nashat Y. Gabrail
No Relationships to Disclose
 
Barbara B. Haley
No Relationships to Disclose
 
Hung T. Khong
Stock and Other Ownership Interests - Apricus Biosciences; Aptose Biosciences; Array BioPharma; Exelixis; Immunomedics; KaloBios; MEI Pharma; TG Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Elizabeth Carloss Riley
No Relationships to Disclose
 
Leigh Ervin
Employment - Innocrin Pharma
Stock and Other Ownership Interests - Innocrin Pharma
 
Joel Robert Eisner
Employment - Innocrin Pharma
Stock and Other Ownership Interests - Innocrin Pharma
 
Edwina Baskin-Bey, M.D.
Employment - Innocrin Pharma
Leadership - Innocrin Pharma
Stock and Other Ownership Interests - Innocrin Pharma
 
William Richard Moore
Employment - Innocrin Pharma
Leadership - Innocrin Pharma
Stock and Other Ownership Interests - Innocrin Pharma
Patents, Royalties, Other Intellectual Property - Innocrin Pharma
 
Tiffany A. Traina
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Genentech/Roche; Immunomedics; Medivation; Merck; Mundipharma; Pfizer
Research Funding - AstraZeneca; Eisai; Innocrin Pharma; Medivation; Myriad Genetics; Novartis; Pfizer